Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Carolyn F. Deacon
,
Jens Juul Holst
Endocrinology and Metabolism
108
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Linagliptin
100%
Dipeptidyl-Peptidase IV Inhibitors
81%
Xanthine
79%
Type 2 Diabetes Mellitus
46%
Hypoglycemic Agents
23%
Clinical Studies
17%
Incretins
16%
Glucagon-Like Peptide 1
14%
Hypoglycemia
11%
Blood Proteins
10%
Therapeutics
10%
Fasting
9%
Pharmacokinetics
9%
Hormones
8%
Clinical Trials
8%
Glucose
7%
Enzymes
6%
Liver
6%
Pharmaceutical Preparations
5%